Columbia Laboratories shares fell 40 percent last Friday after it was reported the FDA declined Watson Pharmaceuticals formal dispute-resolution request, which was filed in August, related to its New Drug Application for Prochieve.
Going forward ... (see research report)
Copyright ® 2016. The Bedford Report. All Rights Reserved.